Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Recognizing the warning signs of a flawed financial plan is essential. This article details indicators that signal the need for a financial review.
23,541 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
The administration re-ignites a plan to bar large investors from single-family home purchases. Analysts question whet...
NuScale Power has seen wild swings, but the story isn’t just nostalgia for a boom. This piece breaks down the odds of...
Choosing between climate-aligned global ETFs and broad international funds can shape your portfolio for years. This g...
Palantir’s AI-enabled analytics engine has fueled growth, but the stock faces multiple headwinds. This article lays o...
As geopolitical shocks push oil prices around, crypto traders turn hyperliquid venues to pursue oil-based bets. Learn...
A Tuesday uptick in Edgewise Therapeutics stock topped the market, driven by an upbeat price target from a major bank...
When a single security gap triggers a major depeg, everyday investors feel the impact first. This article unpacks res...
Policy watchers say a White House-backed regulatory milestone could open crypto and private equity to trillions in re...
Investors weigh income reliability and risk as markets shift. A $1.5 million portfolio that pays roughly $83,400 annu...
IMDX kicked off 2026 with a solid Q1 showing, delivering revenue growth and improving margins while guiding higher fu...
SpaceX is rumored to target a June 12 IPO, igniting widespread speculation about a valuation that could dwarf most te...